Sienna Biopharmaceuticals, Inc.
SNNAQ · OTC
9/30/2019 | 6/30/2019 | 3/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Market Cap | $6 | $27 | $58 | $48 |
| - Cash | $11 | $49 | $57 | $49 |
| + Debt | $0 | $30 | $30 | $30 |
| Enterprise Value | -$5 | $8 | $31 | $30 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$9 | -$8 | -$16 | -$20 |
| % Margin | – | – | – | – |
| Net Income | -$4 | -$8 | -$16 | -$19 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.13 | -0.27 | -0.67 | -0.93 |
| % Growth | 51.9% | 59.7% | 28% | – |
| Operating Cash Flow | -$18 | -$8 | -$13 | -$16 |
| Capital Expenditures | $0 | $0 | -$0 | -$0 |
| Free Cash Flow | -$18 | -$8 | -$13 | -$16 |